Business Wire



CO.DON AG: Positive opinion from CHMP for EU approval of articular cartilage product

In the course of the ongoing application for EU marketing authorisation CO.DON AG received today the official positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for its articular cartilage product. The recommended indication is the repair of symptomatic articular cartilage defects on the femoral condyle and the knee patella; defects of up to 10 cm² for adults. The positive opinion by CHMP forms the basis for a decision by the European Commission on EU-wide marketing authorisation for the product. In the past, the European Commission followed the recommendations of the CHMP in the overwhelming number of applications.

Language:   English
Company: CO.DON AG
Warthestraße 21 14513
Phone: 03328 43460
Fax: 03328 434643


ISIN: DE000A1K0227
WKN: A1K022
Listed: Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in
Berlin, Dusseldorf, Hamburg, Stuttgart, Tradegate Exchange


Matthias Meißner, M.A.
Investor relations

Information om Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco